Skip to main content

Table 2 Univariate analysis for the risk of recurrence of HCC after RFA

From: Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound

Parameter

All patients (n = 420)

Patients with recurrence (n = 348)

Patients without recurrence (n = 62)

Univariate hazard ratio (95% confidence interval)

P

Multivariate hazard ratio (95% confidence interval)

P

Age

57.07 ± 9.31

58.32 ± 8.97

55.72 ± 9.52

0.992 (0.927, 1.063)

0.8288

0.992 (0.927, 1.06)

0.8288

Tumor size

32.44 ± 10.64

38.81 ± 9.47

25.49 ± 6.81

1.267 (1.148, 1.398)

0.0001

1.267 (1.148, 1.398)

0.0001

BPC

99.45 ± 59.81

95.05 ± 54.01

104.24 ± 65.46

1.000 (0.992, 1.008)

0.9839

1.000 (0.992, 1.008)

0.9839

BIL

21.05 ± 17.85

22.26 ± 16.58

19.74 ± 19.13

0.981 (0.917, 1.049)

0.5683

0.981 (0.917, 1.049)

0.5683

Albumin

36.91 ± 6.46

35.76 ± 6.14

38.15 ± 6.60

0.998 (0.880, 1.132)

0.974

0.998 (0.880, 1.132)

0.974

PT

14.53 ± 1.98

14.79 ± 2.11

14.24 ± 1.79

1.056 (0.694, 1.608)

0.7988

1.056 (0.694, 1.608)

0.7988

HBV-DNA

3.45 ± 1.77

4.62 ± 1.68

2.18 ± 0.57

7.699 (3.566, 16.625)

0.0001

7.699 (3.566, 16.625)

0.0001

AFP

1.367 ± 1.68

1.95 ± 1.69

0.73 ± 1.72

2.172 (1.256, 3.756)

0.0055

2.172 (1.256, 3.756)

0.0055

AFP response

0.531 ± 0.500

0.514 ± 0.502

0.549 ± 0.500

4.722 (1.053, 21.184)

0.0427

4.722 (1.053, 21.184)

0.0427

  1. BPC blood platelet count, BIL total bilirubin, PT prothrombin time, AFP α-fetoprotein, HBV hepatitis B virus